Signal transduction in hepatic stellate cells and possible drug targets

Chinese Pharmacological Bulletin

Volumn 22, Issue 12, 2006, Pages 1433-1438

  Sun, Wu Yi ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic stellate cells; Liver fibrosis; Signal transduction

Indexed keywords

ARTICLE; LIVER FIBROSIS; MEDICAL LITERATURE; MEDICAL RESEARCH; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 33847019601     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Friedman S L, Bansal M B. Reversal of hepatic fibrosis-Fact or fantasy [J]? Hepatology, 2006, 43(2 Suppl 1): S82-8.
2. J Guyot C, Lepreux S, Combe C, et al. Hepatic fibrosis and cirrhosis: the (myo) fibroblastic cell subpopulations involved [J]. Int J Biochem Cell Biol, 2006, 38(2): 135-51.
3. Schnabl B, Hu K, Muhlbauer M, et al. Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10 [J]. Biochem Biophys Res Commun, 2005, 335(1): 87-96.
4. Takahra T, Smart D E, Oakley F, Mann D A. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures; regulation by NF-kappaB, AP-1 and Sp1 [J]. Int J Biochem Cell Biol, 2004, 36(2): 353-63.
5. Gilmore T D. The Rel/NF-kappa B/I kappa B signal transduction pathway and cancer [J]. Cancer Treat Res, 2003, 115: 241-65.
6. Wang X, Tang X, Gong X, et al. Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2 [J]. Gastroenterology, 2004, 127(4): 1174-88.
7. Breitkopf K, Roeyen C, Sawitza I et al. Expression patterns of PDGF-A, -B, -C and-D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells(HSC) [J]. Cytokine, 2005, 31 (5): 349-57.
8. Marra F, Arrighi M C, Fazi M, et al. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factors actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat [J]. Hepatology, 1999, 30(4): 951-8.
9. Reeves H L, Thompson M G, Dack C L, et al. The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells [J]. Hepatology, 2000, 31(1): 95-100.
10. Schnabl B, Bradham C A, Bennett B L, et al. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells [J]. Hepatology, 2001, 34(5): 953-63.
11. Koide S, Kobayashi Y, Oki Y, Nakamura H. Prostaglandin E2 inhibits platelet-derived growth factor-stimulated cell proliferation through a prostaglandin E receptor EP2 subtype in rat hepatic stellate cells [J]. Dig Dis Sci, 2004, 49(9): 1394-400.
12. Failli P, De Franco R M, Caligiuri A, et al. Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells [J]. Gastroenterology, 2000, 119(2): 479-92.
13. Wymann M P, Marone R. Phosphoinositide 3-kinase in disease: timing, location, and scaffolding [J]. Curr Opin Cell Biol, 2005, 17(2): 141-9.
14. Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer [J]. Apoptosis, 2004, 9(6): 667 -76.
15. Reif S, Lang A, Lindquist J N, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression [J]. J Biol Chem, 2003, 278(10): 8083-90.
16. Caligiuri A, Franco R M, Romanelli R G, et al. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells [J]. Gastroenterology, 2003, 124(2): 504-20.
17. Carloni V, Defranco R M, Caligiuri A, et al. Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cells [J]. Hepatology, 2002, 36(3): 582-91.
18. Jones S M, Kazlauskas A. Growth-factor-dependent mitogenesis requires two distinct phases of signalling [J]. Nat Cell Biol, 2001, 3(2): 165-72.
19. Gingras A C, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/Mtor [J]. Genes Dev, 2001, 15(7): 807-26.
20. Gabele E, Reif S, Tsukada S, et al. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation [J]. J Biol Chem, 2005, 280(14):13374-82.
21. Shek F W, Benyon R C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis [J]? Eur J Gastroenterol Hepatol, 2004, 16(2): 123-6.
22. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus [J]. Cell, 2003, 113(6): 685-700.
23. Leask A, Abraham D J. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology [J]. Biochem Cell Biol, 2003, 81(6): 355-63.
24. Rachfal A W, Brigstock D R. Connective tissue growth factor(CT-GF/CCN2) in hepatic fibrosis [J]. Hepatol Res, 2003, 26(1): 1 -9.
25. Tsukada S, Westwick J K, Ikejima K, et al. SMAD and p38 MAPK signaling pathways independently regulate alpha1 ( I ) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells [J]. J Biol Chem, 2005, 280(11): 10055-64.
26. Furukawa F, Matsuzaki K, Mori S, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts [J]. Hepatology, 2003, 38(4): 879-89.
27. Brun P, Castagliuolo I, Pinzani M, et al. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells [J]. Am J Physiol Gastrointest Liver Physiol, 2005, 289(3): G571-8.
28. Chinese source
29. Zhang XF, Lu Z P, Liu X Y. The progression for the therapy of liver fibrosis targeting to hepatic stellate cells [J]. Chin Pharmacol Bull, 2003, 19(6): 622-6.